İÇLİ, F. Et Al. 2002. Paclitaxel (T) vs cisplatin VP-16 (EP) in metastatic breast cancer patients treated with anthracyclines: A phase III randomized study, Turkish Oncology Group. Proceedings of European Society of Clinical Oncology .

İÇLİ, F., AKBULUT, H., ÜNER, A., YALÇIN, B., ALTINBAŞ, M., BALTALI, E., ... KÖMÜRCÜ, Ş.(2002). Paclitaxel (T) vs cisplatin VP-16 (EP) in metastatic breast cancer patients treated with anthracyclines: A phase III randomized study, Turkish Oncology Group . Proceedings of European Society of Clinical Oncology

İÇLİ, FİKRİ Et Al. "Paclitaxel (T) vs cisplatin VP-16 (EP) in metastatic breast cancer patients treated with anthracyclines: A phase III randomized study, Turkish Oncology Group," Proceedings of European Society of Clinical Oncology, 2002

İÇLİ, FİKRİ Et Al. "Paclitaxel (T) vs cisplatin VP-16 (EP) in metastatic breast cancer patients treated with anthracyclines: A phase III randomized study, Turkish Oncology Group." Proceedings of European Society of Clinical Oncology , 2002

İÇLİ, F. Et Al. (2002) . "Paclitaxel (T) vs cisplatin VP-16 (EP) in metastatic breast cancer patients treated with anthracyclines: A phase III randomized study, Turkish Oncology Group." Proceedings of European Society of Clinical Oncology .

@conferencepaper{conferencepaper, author={FİKRİ İÇLİ Et Al. }, title={Paclitaxel (T) vs cisplatin VP-16 (EP) in metastatic breast cancer patients treated with anthracyclines: A phase III randomized study, Turkish Oncology Group}, congress name={Proceedings of European Society of Clinical Oncology}, city={}, country={}, year={2002}}